Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
100 d » 100 μ (Expand Search), 100 _ (Expand Search), 100 g (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
100 d » 100 μ (Expand Search), 100 _ (Expand Search), 100 g (Expand Search)
-
721
-
722
-
723
-
724
-
725
Decreased expression of genes related to cholesterol biosynthesis and lipogenesis in PCA.
Published 2012“…The results of the analysis for LPP are shown in 1A, for CCCA in 1B, for FFA in 1C and for TF in 1D. …”
-
726
-
727
-
728
-
729
-
730
-
731
-
732
Adenosine decreases the amplitude of evoked AMPA EPSCs via activation of A<sub>1</sub> ARs without altering that of the evoked IPSCs recorded from layer III pyramidal neurons in th...
Published 2013“…<b>F,</b> Bath application of dipyridamole (1 µM), an adenosine transporter inhibitor, significantly reduced the evoked EPSCs (n = 10, p<0.001, paired t-test) suggesting that endogenously released adenosine decreases AMPA EPSCs. <b>G,</b> Prior application of DPCPX, an A<sub>1</sub> AR blocker, blocked dipyridamole-induced depression of AMPA EPSCs (n = 5, p = 0.85 vs. baseline, paired t-test) suggesting that the inhibitory effect of dipyridamole is mediated via activation of A<sub>1</sub> ARs. …”
-
733
-
734
-
735
-
736
-
737
-
738
-
739
-
740